The Asia-Pacific Longevity Medicine Society (APLMS), in partnership with The Kitalys Institute, announced that the 2026 Asia-Pacific Healthy Longevity International Summit (APAC-LMIS) will be held in Hong Kong from October 1–4, 2026, at the Hopewell Hotel.
The Summit is expected to bring together more than 2,000 global leaders across longevity medicine, geroscience, pharmas, digital health, artificial intelligence, and regulatory science. As aging populations reshape healthcare systems and economic priorities worldwide, the event positions Hong Kong as a strategic hub for advancing innovation and collaboration in the rapidly expanding longevity economy.
Organized under the theme “From Vision to Action in Healthy Longevity,” the Summit will focus on accelerating the translation of scientific breakthroughs into scalable clinical practice and real-world health solutions.
Pre-summit programs (October 1–2) will include a curated series of high-impact activities, such as the Global Top 10 Longevity Breakthrough Awards, executive training for longevity clinic leaders, and expert-led sessions on regulatory frameworks and emerging technologies. The main Summit (October 3–4) will emphasize cross-sector collaboration, bringing together academia, healthcare providers, industry innovators, and policymakers to define next-generation standards, investment pathways, and delivery models in healthy longevity.
A central focus of the Summit will be the role of longevity clinics as the front line of clinical translation, alongside the integration of lifestyle medicine, digital health platforms, and AI-driven systems to enable earlier, more personalized interventions.
“The future of longevity medicine is no longer just about scientific discovery—it is about implementation at scale,” said the organizers. “This Summit is designed to connect research, clinical practice, regulation, and investment to accelerate real-world impact.”
With strong support from regional partners and growing international participation, the 2026 APAC-LMIS is expected to become a flagship global platform for advancing healthy longevity across the Asia-Pacific region and beyond.
Contact email: bd@apaclongevitysociety.org
About The Asia-Pacific Longevity Medicine Society (APLMS) www.apaclongevitysociety.org
The mission of APLMS is to promote the vision of “Live Longer, Live Healthier and Embrace the Best Lifestyle.”
The Asia-Pacific Longevity Medicine Society (APLMS) is a newly established non-profit professional organization registered in Hong Kong, China. Its founding member regions and countries include Mainland China, Hong Kong, Taiwan, Macau, Japan, South Korea, Singapore, Thailand, Australia and India.
APLMS is governed by a nine-member Executive Board, with each member representing one of the founding regions or countries. Dr. Tim Z. Shi, MD, PhD, Chief Representative of the GlobalMD Organization China Office, has been elected to serve as the Founding Chairman.
Additionally, APLMS has appointed twenty-one international advisory board members, representing global expertise across longevity medicine, geroscience, precision medicine, longevity technology, functional medicine, AI and digital health, clinical research and the pharmaceutical sector.
Key Focus Areas:
- Education and Advisory: Hosting conferences and creating educational content for scientists, industry leaders, longevity clinics, and the public;
- Collaboration: Building a network of researchers, entrepreneurs and investors dedicated to the longevity field;
- Coordination: Initiating and coordinating regional clinical trials and facilitating data sharing across member countries;
- Policy: Advocating for regulatory frameworks that support the advancement of longevity therapeutics.
Global Top 10 Longevity Breakthrough Awards:
About The Kitalys Institute
Kitalys Institute (www.kitalys.org) is a 501©(3) tax-exempt not-for-profit organization dedicated to accelerating the translation of science into public health to prevent chronic diseases and extend healthy longevity for all. Kitalys, and previously, its affiliate, Kinexum, a life sciences strategic advisory firm (www.kinexum.com), have been organizing the Targeting Healthy Longevity (previously Targeting Metabesity) conference, which since 2017 has convened leaders of NIH, FDA, Congress, the UK Parliament, geroscience and chronic disease research, industry and capital markets to identify obstacles and solutions to the emergence of the age of healthy longevity for all. Over 200 conference sessions are posted on Kitalys’s YouTube channel at www.healthy-longevity.org. Kitalys has advised XPRIZE Healthspan and ARPA-H PROSPR on strategic regulatory matters, and proposed draft legislation, the THRIVE Act, that establishes an optional regulatory pathway, escalating tiers of evidence and incentives for drugs, devices and supplements that increase healthspan, while Kinexum represents a number of longevity biotech companies, including semi-finalists in XPRIZE Healthspan.
View the article at lifespan.io
